C. Dormuth

发表

Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real‐world example

Andrea Benedetti, Robert W Platt, Kristian B Filion, 2019, Pharmacoepidemiology and drug safety.

Commitment to change statements can predict actual change in practice

Malcolm Maclure, Carol P. Herbert, John Premi, 2003, The Journal of continuing education in the health professions.

Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.

Michael L. Johnson, U. Siebert, W. Crown, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

CNODES: the Canadian Network for Observational Drug Effect Studies

A. Levy, B. Hemmelgarn, R. Platt, 2012, Open medicine : a peer-reviewed, independent, open-access journal.

Time course for blood pressure lowering of beta-blockers with partial agonist activity.

C. Dormuth, V. Musini, Xiao-Yin Zhang, 2020, The Cochrane database of systematic reviews.

Time course for blood pressure lowering of beta-blockers with partial agonist activity.

C. Dormuth, V. Musini, Xiao-Yin Zhang, 2012, The Cochrane database of systematic reviews.

Algorithms to estimate the beginning of pregnancy in administrative databases

S. Hernández-Díaz, R. Glynn, M. Mittleman, 2013, Pharmacoepidemiology and drug safety.

Net Health Plan Savings From Reference Pricing for Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia Residents

S. Schneeweiss, S. Soumerai, M. Maclure, 2004, Medical care.

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Pierre Ernst, Robert W. Platt, Jacques LeLorier, 2016, JAMA internal medicine.

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits

T. Gomes, D. Juurlink, M. Mamdani, 2019, BMJ Open.

A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.

Pierre Ernst, Robert W Platt, Laurent Azoulay, 2016, The New England journal of medicine.

Medications to reduce emergence coughing after general anaesthesia with tracheal intubation: a systematic review and network meta-analysis.

C. Dormuth, D. Griesdale, A. Tung, 2020, British journal of anaesthesia.

Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug‐safety article

A. Gruzd, C. Dormuth, I. Sketris, 2018, Pharmacoepidemiology and drug safety.

Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

P. Souverein, M. D. De Bruin, J. Lexchin, 2022, Drug Safety.

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

L. Lix, S. Suissa, C. Dormuth, 2020, BMJ.

Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study.

Garry Gray, C. Dormuth, B. Mintzes, 2021, Clinical therapeutics.

Pharmaceutical cost containment with reference-based pricing: time for refinements.

J. Avorn, S. Schneeweiss, M. Maclure, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Time course for blood pressure lowering of angiotensin receptor blockers

James M. Wright, C. Dormuth, P. Yen, 2017 .

Time course for blood pressure lowering of dihydropyridine calcium channel blockers.

James M. Wright, C. Dormuth, Niousha Ghamami, 2014, The Cochrane database of systematic reviews.

Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004

S. Schneeweiss, N. Choudhry, C. Dormuth, 2011, Pharmacoepidemiology and drug safety.

The Impact of Mandatory Nonmedical Switching From Originator to Biosimilar Insulin Glargine.

C. Dormuth, Anat Fisher, Jason D. Kim, 2022, Clinical therapeutics.

Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia

James M. Wright, M. Maclure, J. McCormack, 1998, The Lancet.

Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial

James M. Wright, M. Maclure, C. Dormuth, 2004, Canadian Medical Association Journal.

Better Prescribing Project: a randomized controlled trial of the impact of case-based educational modules and personal prescribing feedback on prescribing for hypertension in primary care.

M. Maclure, C. Dormuth, J. Légaré, 2004, Family practice.

Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study

M. Hudson, R. Platt, C. Dormuth, 2020, The Journal of Rheumatology.

Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.

J. Avorn, S. Schneeweiss, Philip S. Wang, 2010, The journal of mental health policy and economics.

The impact of cost sharing on antidepressant use among older adults in British Columbia.

J. Avorn, S. Schneeweiss, Philip S. Wang, 2008, Psychiatric services.

Author’s reply to Phillips and Brugts

C. Dormuth, 2014, BMJ : British Medical Journal.

First‐line diuretics versus other classes of antihypertensive drugs for hypertension

D. Salzwedel, C. Dormuth, V. Musini, 2011 .

Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis

M. Brookhart, C. Dormuth, K. Bassett, 2016, PloS one.

Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia

C. Dormuth, K. Bassett, K. Maclure, 2019, Pharmacoepidemiology and drug safety.

Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children

M. Maclure, C. Dormuth, Richard L. Morrow, 2012, Canadian Medical Association Journal.

Validating studies of adherence through the use of control outcomes and exposures.

M. Brookhart, W. Shrank, A. Patrick, 2010, American journal of hypertension.

Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study

E. Roughead, P. Souverein, C. Dormuth, 2022, Pharmacoepidemiology and drug safety.

Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use.

M Alan Brookhart, Sebastian Schneeweiss, Daniel H Solomon, 2007, Archives of internal medicine.

Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy

R. Platt, G. Teare, C. Dormuth, 2016, Canadian Medical Association Journal.

Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom

Robert W. Platt, A. Levy, L. Lix, 2022, BMC Endocrine Disorders.

Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study.

G. Hawker, D. Juurlink, M. Mamdani, 2013, CMAJ open.

Thiazolidinediones and fractures in men and women.

B. Carleton, C. Dormuth, K. Bassett, 2009, Archives of internal medicine.

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect.

J. Avorn, M. Brookhart, W. Shrank, 2007, American journal of epidemiology.

Influence of opioid prescribing standards on drug use among patients with long-term opioid use: a longitudinal cohort study.

C. Dormuth, K. Bassett, Richard L. Morrow, 2019, CMAJ open.

Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada

C. Dormuth, K. Bassett, G. Carney, 2022, BMJ Open Diabetes Research & Care.

Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage

C. Dormuth, J. Paterson, S. Cadarette, 2011, Osteoporosis International.

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients

S. Schneeweiss, Philip S. Wang, C. Dormuth, 2007, Canadian Medical Association Journal.

Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study

Robert W. Platt, S. Suissa, P. Reynier, 2022, PloS one.

Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study

C. Dormuth, Anat Fisher, Jason D. Kim, 2022, CMAJ open.

Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study

M. Brookhart, C. Dormuth, K. Bassett, 2014, PloS one.

Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts

Sebastian Schneeweiss, Daniel H Solomon, S. Schneeweiss, 2010, Pediatrics.

Pharmacological methods for reducing coughing on emergence from elective surgery after general anesthesia with endotracheal intubation: protocol for a systematic review of common medications and network meta-analysis

C. Dormuth, D. Griesdale, A. Tung, 2019, Systematic Reviews.

Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study

M. Maclure, C. Dormuth, K. Bassett, 2019, BMJ Open.

Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities

Chris Cameron, Doug Coyle, George Wells, 2015, Systematic Reviews.

Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

D. Juurlink, M. Mamdani, C. Dormuth, 2013, The Journal of investigative dermatology.

Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort

M. Brookhart, C. Dormuth, K. Bassett, 2014, BMJ Open.

Statin Adherence and Risk of Accidents: A Cautionary Tale

James M Wright, M Alan Brookhart, Robert J Glynn, 2009, Circulation.

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events

D. Juurlink, M. Mamdani, C. Dormuth, 2013, PloS one.

Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study

C. Dormuth, Anat Fisher, Jason D. Kim, 2023, Gastroenterology research and practice.

A therapeutic substitution policy for proton pump inhibitors: Clinical and economic consequences

J. Avorn, S. Schneeweiss, R. Glynn, 2006, Clinical pharmacology and therapeutics.

Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.

C. Dormuth, K. Bassett, Yuko Kawasumi, 2013, Clinical therapeutics.

Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.

M. Maclure, C. Dormuth, K. Bassett, 2020, Addiction.

Likelihood ratio meta-analysis: New motivation and approach for an old method.

R. Platt, C. Dormuth, K. Filion, 2016, Contemporary clinical trials.

Impact of rosiglitazone meta-analysis on use of glucose-lowering medications

C. Dormuth, K. Bassett, Richard L. Morrow, 2010, Open medicine : a peer-reviewed, independent, open-access journal.

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study

L. Lix, B. Hemmelgarn, M. J. Paterson, 2017, British Medical Journal.

Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization

S. Schneeweiss, R. Glynn, S. Soumerai, 2022 .

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

S. Schneeweiss, R. Glynn, S. Soumerai, 2002, The New England journal of medicine.

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods

Jacques LeLorier, E. Rahme, C. Dormuth, 2016, BMC Medical Research Methodology.

A population‐based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns

M. Secrest, C. Dormuth, K. Filion, 2020, Pharmacoepidemiology and drug safety.

Individualized prescribing portraits to reduce inappropriate initiation of opioid analgesics to opioid naïve patients in primary care: Protocol for a randomized controlled trialb.

M. Maclure, C. Dormuth, E. Wood, 2021, Contemporary clinical trials.

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases

A. Garg, A. Levy, M. James, 2013, BMJ.

Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research

M. Maclure, C. Dormuth, K. Bassett, 2019, Pharmacoepidemiology and drug safety.

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort

R. Platt, S. Suissa, P. Reynier, 2021, JAMA network open.

Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol

A. Holbrook, C. Dormuth, Agnes Y. Y. Lee, 2016, BMJ Open.

Adherence to Statin Therapy Under Drug Cost Sharing in Patients With and Without Acute Myocardial Infarction: A Population-Based Natural Experiment

S. Schneeweiss, R. Glynn, A. Patrick, 2007, Circulation.

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases

Kristian B Filion, Hala Tamim, M. James, 2014, BMJ : British Medical Journal.

Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction.

S. Schneeweiss, R. Glynn, A. Patrick, 2007, The American journal of managed care.

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study

D. Juurlink, R. Platt, C. Dormuth, 2016, British Medical Journal.

Statins for primary prevention

C. Dormuth, K. Bassett, J. Wright, 2012, Canadian Medical Association Journal.

Factors relating to nonpublication and publication bias in clinical trials in Canada: A qualitative interview study

Garry Gray, C. Dormuth, B. Mintzes, 2022, British journal of clinical pharmacology.

Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study

Garry Gray, C. Dormuth, B. Mintzes, 2023, BMJ Open.

On the Evaluation of Drug Benefits Policy Changes with Longitudinal Claims Data

S. Schneeweiss, M. Maclure, C. Dormuth, 2002 .

Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers

S. Schneeweiss, R. Glynn, S. Soumerai, 2003, Clinical pharmacology and therapeutics.

Seasonal effects on the occurrence of nocturnal leg cramps: a prospective cohort study

Karim M. Khan, K. Khan, C. Dormuth, 2015, Canadian Medical Association Journal.

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

P. Ravani, G. Teare, C. Dormuth, 2013, Gut.

Long‐Term Use of Proton Pump Inhibitors and Community‐Acquired Pneumonia: Adverse Effect or Bias?

C. Dormuth, K. Filion, H. T. Ayele, 2018, Journal of the American Geriatrics Society.

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

P. Souverein, R. Ofori-Asenso, M. D. De Bruin, 2022, BMJ Quality & Safety.

Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research

R. Platt, M. Secrest, C. Dormuth, 2020, Pharmacoepidemiology and drug safety.

Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

S. Schneeweiss, Philip S. Wang, A. Patrick, 2010, Archives of general psychiatry.

How do safety warnings on medicines affect prescribing?

C. Dormuth, P. Bahri, B. Mintzes, 2022, Expert opinion on drug safety.

The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults.

J. Avorn, R. Glynn, M. Brookhart, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.

S. Schneeweiss, R. Glynn, M. Maclure, 2006, Clinical therapeutics.

Using policy simulation to predict drug plan expenditure when planning reimbursement changes

Sebastian Schneeweiss, S. Schneeweiss, C. Dormuth, 2012, PharmacoEconomics.

Evaluating the Validity of an Instrumental Variable Study of Neuroleptics: Can Between-Physician Differences in Prescribing Patterns Be Used to Estimate Treatment Effects?

J. Rassen, S. Schneeweiss, Philip S. Wang, 2007, Medical care.

Characteristics and Incidence of Opioid Analgesic Initiations to Opioid Naïve Patients in a Canadian Primary Care Setting

M. Maclure, C. Dormuth, Huiru Dong, 2022, Canadian Journal of Addiction.

Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis.

Karim M Khan, K. Khan, C. Dormuth, 2012, Archives of internal medicine.

Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching

C. Dormuth, K. Bassett, Anat Fisher, 2017, Drugs & Aging.

Comparative Safety of Smoking Cessation Pharmacotherapies During a Government-Sponsored Reimbursement Program.

M. Maclure, C. Dormuth, K. Bassett, 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Dyslipidemia in Muscular Dystrophy: A Systematic Review and Meta-Analysis

P. Bernatchez, C. Dormuth, Zeren Sun, 2023, Journal of neuromuscular diseases.

Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines

D. Juurlink, M. Mamdani, C. Dormuth, 2012, Canadian Medical Association Journal.

Time series evaluation of an intervention to increase statin tablet splitting by general practitioners.

S. Schneeweiss, M. Maclure, C. Dormuth, 2011, Clinical therapeutics.

Effects of Prescription Coinsurance and Income-Based Deductibles on Net Health Plan Spending for Older Users of Inhaled Medications

S. Schneeweiss, R. Glynn, M. Maclure, 2009, Medical care.

Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.

Malcolm Maclure, Peter Neumann, Sebastian Schneeweiss, 2008, Clinical therapeutics.

Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study

C. Dormuth, K. Bassett, G. Carney, 2012, BMJ Open.

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin

S. Schneeweiss, M. Maclure, C. Dormuth, 2009, PloS one.

US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)

C. Dormuth, B. Mintzes, Richard L. Morrow, 2020, Pharmaceutical Medicine.

Trends in antihypertensive drug utilization in British Columbia, 2004–2019: a descriptive study

C. Dormuth, Anat Fisher, Jason D. Kim, 2023, CMAJ open.

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease

R. Steele, P. Khairy, C. Dormuth, 2016, British journal of clinical pharmacology.

Trends in health care utilization in British Columbia following public coverage for tiotropium.

C. Dormuth, Richard L. Morrow, G. Carney, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Comparative health-care cost advantage of ipratropium over tiotropium in COPD patients.

T. Stürmer, C. Dormuth, G. Carney, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.

S. Schneeweiss, R. Glynn, S. Soumerai, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia

C. Dormuth, Anat Fisher, G. Carney, 2020, Pharmacoepidemiology and drug safety.

Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners.

S. Schneeweiss, M. Maclure, K. Ho, 2006, Basic & clinical pharmacology & toxicology.

Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia—An interim report

C. Dormuth, Anat Fisher, Jason D. Kim, 2020, Pharmacoepidemiology and drug safety.

A Randomized Trial Assessing the Impact of a Personal Printed Feedback Portrait on Statin Prescribing in Primary Care

M. Maclure, C. Dormuth, K. Bassett, 2012, The Journal of continuing education in the health professions.

Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities

Robert W. Platt, Dan Chateau, R. Platt, 2016, EGEMS.

Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis

James M Wright, Sebastian Schneeweiss, S. Schneeweiss, 2008, Open medicine : a peer-reviewed, independent, open-access journal.

Comparison of cholinesterase inhibitor safety in real-world practice

M. Maclure, C. Dormuth, K. Bassett, 2019, Alzheimer's & dementia.

Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children

M. Maclure, C. Dormuth, Richard L. Morrow, 2012, Canadian Medical Association Journal.

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

S. Schneeweiss, R. Glynn, Obert, 2002, The New England journal of medicine.

Trends in health care utilization in British Columbia following public coverage for tiotropium.

C. Dormuth, Richard L. Morrow, G. Carney, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.